<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04252729</url>
  </required_header>
  <id_info>
    <org_study_id>4383/16/049</org_study_id>
    <nct_id>NCT04252729</nct_id>
  </id_info>
  <brief_title>Effect of Psychotherapy on Quality of Life and Recurrence of Events in Patients With Recurrent Vasovagal Syncope: A Randomized Pilot Study</brief_title>
  <official_title>Effect of Psychotherapy on Quality of Life and Recurrence of Events in Patients With Recurrent Vasovagal Syncope: A Randomized Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mauricio Ibrahim Scanavacca</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Sao Paulo General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Recurrent vasovagal syncope although presenting a benign prognosis in terms of survival, is
      associated with significant impairment of quality of life. The impaired emotional status is
      also related to the recurrence of the events, closing a negative cycle for the evolution of
      the disease. This study aims to evaluate the effect of psychotherapy on the quality of life
      and in the number of syncope and pre-syncope events during one year of follow-up of patients
      with recurrent vasovagal syncope.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 27, 2017</start_date>
  <completion_date type="Actual">August 23, 2018</completion_date>
  <primary_completion_date type="Actual">August 3, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of life analysis performed by the Short Form 36 Instrument</measure>
    <time_frame>1 week</time_frame>
    <description>Data collected at first visit</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quality of life analysis performed by the Short Form 36 Instrument</measure>
    <time_frame>6 months</time_frame>
    <description>Data collected at first visit, 6 and 12 months (global assessment and by specific domains).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quality of life analysis performed by the Short Form 36 Instrument</measure>
    <time_frame>12 months</time_frame>
    <description>Data collected at 12 months (global assessment and by specific domains).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Demographic data</measure>
    <time_frame>12 months</time_frame>
    <description>Gender, age, date of birth, race, monthly income and education level.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of comorbidities</measure>
    <time_frame>12 months</time_frame>
    <description>Especially use of alcohol, drugs and smoking</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of concomitant medication</measure>
    <time_frame>12 months</time_frame>
    <description>Prescription medication that the participant uses.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Syncope</condition>
  <arm_group>
    <arm_group_label>Psychotherapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Psychotherapy sessions based on the theoretical line of Psychoanalytic Psychosomatics for 1 year, every 10 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No psychotherapy</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Follow-up according to institutional routine, without psychotherapy sessions.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Psychotherapy</intervention_name>
    <description>Psychotherapy sessions based on Psychoanalytic Psychosomatics</description>
    <arm_group_label>Psychotherapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of vasovagal syncope with positive TILT TEST and recurrent episodes (≥2
             episode within 6 months)

          -  Signed Free and Informed Consent Form

        Exclusion Criteria:

          -  Severe comorbidity with life expectancy &lt;1 year

          -  Age &lt;18 years

          -  Current psychotherapeutic follow-up

          -  Cardiac or neurological syncope

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Instituto do Coração - Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo</name>
      <address>
        <city>Sao Paulo</city>
        <state>SP</state>
        <zip>05403010</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>January 21, 2020</study_first_submitted>
  <study_first_submitted_qc>January 30, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 5, 2020</study_first_posted>
  <last_update_submitted>January 30, 2020</last_update_submitted>
  <last_update_submitted_qc>January 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Sao Paulo General Hospital</investigator_affiliation>
    <investigator_full_name>Mauricio Ibrahim Scanavacca</investigator_full_name>
    <investigator_title>Arrhythmia Clinical Unit Director</investigator_title>
  </responsible_party>
  <keyword>Psychotherapy</keyword>
  <keyword>Syncope</keyword>
  <keyword>Quality of life</keyword>
  <keyword>Psychoanalytic psychosomatics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syncope</mesh_term>
    <mesh_term>Syncope, Vasovagal</mesh_term>
    <mesh_term>Recurrence</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

